Cargando…

Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease

The objective of this study is to investigate the value of dual-task performance for the prediction of falls in patients with Parkinson’s disease (PD). Two hundred sixty-three patients with PD (H&Y 1–3, 65.2 ± 7.9 years) walked two times along a 10-m trajectory, both under single-task and dual-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Smulders, Katrijn, Esselink, Rianne A. J., Weiss, Aner, Kessels, Roy P. C., Geurts, Alexander C. H., Bloem, Bastiaan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432779/
https://www.ncbi.nlm.nih.gov/pubmed/22294215
http://dx.doi.org/10.1007/s00415-012-6419-4
_version_ 1782242245522489344
author Smulders, Katrijn
Esselink, Rianne A. J.
Weiss, Aner
Kessels, Roy P. C.
Geurts, Alexander C. H.
Bloem, Bastiaan R.
author_facet Smulders, Katrijn
Esselink, Rianne A. J.
Weiss, Aner
Kessels, Roy P. C.
Geurts, Alexander C. H.
Bloem, Bastiaan R.
author_sort Smulders, Katrijn
collection PubMed
description The objective of this study is to investigate the value of dual-task performance for the prediction of falls in patients with Parkinson’s disease (PD). Two hundred sixty-three patients with PD (H&Y 1–3, 65.2 ± 7.9 years) walked two times along a 10-m trajectory, both under single-task and dual-task (DT) conditions (combined with an auditory Stroop task). To control for a cueing effect, Stroop stimuli were presented at variable or fixed 1- or 2-s intervals. The auditory Stroop task was also performed alone. Dual-task costs were calculated for gait speed, stride length, stride time, stride time variability, step and stride regularity, step symmetry and Stroop composite scores (accuracy/reaction time). Subsequently, falls were registered prospectively for 1 year (monthly assessments). Patients were categorized as non-recurrent fallers (no or 1 fall) or recurrent fallers (>1 falls). Recurrent fallers (35%) had a significantly higher disease severity, lower MMSE scores, and higher Timed “Up & Go” test scores than non-recurrent fallers. Under DT conditions, gait speed and stride lengths were significantly decreased. Stride time, stride time variability, step and stride regularity, and step symmetry did not change under DT conditions. Stroop dual-task costs were only significant for the 2-s Stroop interval trials. Importantly, recurrent fallers did not show different dual-task costs compared to non-recurrent fallers on any of the gait or Stroop parameters. These results did not change after correction for baseline group differences. Deterioration of gait or Stroop performance under dual-task conditions was not associated with prospective falls in this large sample of patients with PD.
format Online
Article
Text
id pubmed-3432779
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-34327792012-09-07 Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease Smulders, Katrijn Esselink, Rianne A. J. Weiss, Aner Kessels, Roy P. C. Geurts, Alexander C. H. Bloem, Bastiaan R. J Neurol Original Communication The objective of this study is to investigate the value of dual-task performance for the prediction of falls in patients with Parkinson’s disease (PD). Two hundred sixty-three patients with PD (H&Y 1–3, 65.2 ± 7.9 years) walked two times along a 10-m trajectory, both under single-task and dual-task (DT) conditions (combined with an auditory Stroop task). To control for a cueing effect, Stroop stimuli were presented at variable or fixed 1- or 2-s intervals. The auditory Stroop task was also performed alone. Dual-task costs were calculated for gait speed, stride length, stride time, stride time variability, step and stride regularity, step symmetry and Stroop composite scores (accuracy/reaction time). Subsequently, falls were registered prospectively for 1 year (monthly assessments). Patients were categorized as non-recurrent fallers (no or 1 fall) or recurrent fallers (>1 falls). Recurrent fallers (35%) had a significantly higher disease severity, lower MMSE scores, and higher Timed “Up & Go” test scores than non-recurrent fallers. Under DT conditions, gait speed and stride lengths were significantly decreased. Stride time, stride time variability, step and stride regularity, and step symmetry did not change under DT conditions. Stroop dual-task costs were only significant for the 2-s Stroop interval trials. Importantly, recurrent fallers did not show different dual-task costs compared to non-recurrent fallers on any of the gait or Stroop parameters. These results did not change after correction for baseline group differences. Deterioration of gait or Stroop performance under dual-task conditions was not associated with prospective falls in this large sample of patients with PD. Springer-Verlag 2012-02-01 2012 /pmc/articles/PMC3432779/ /pubmed/22294215 http://dx.doi.org/10.1007/s00415-012-6419-4 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Communication
Smulders, Katrijn
Esselink, Rianne A. J.
Weiss, Aner
Kessels, Roy P. C.
Geurts, Alexander C. H.
Bloem, Bastiaan R.
Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
title Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
title_full Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
title_fullStr Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
title_full_unstemmed Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
title_short Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
title_sort assessment of dual tasking has no clinical value for fall prediction in parkinson’s disease
topic Original Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432779/
https://www.ncbi.nlm.nih.gov/pubmed/22294215
http://dx.doi.org/10.1007/s00415-012-6419-4
work_keys_str_mv AT smulderskatrijn assessmentofdualtaskinghasnoclinicalvalueforfallpredictioninparkinsonsdisease
AT esselinkrianneaj assessmentofdualtaskinghasnoclinicalvalueforfallpredictioninparkinsonsdisease
AT weissaner assessmentofdualtaskinghasnoclinicalvalueforfallpredictioninparkinsonsdisease
AT kesselsroypc assessmentofdualtaskinghasnoclinicalvalueforfallpredictioninparkinsonsdisease
AT geurtsalexanderch assessmentofdualtaskinghasnoclinicalvalueforfallpredictioninparkinsonsdisease
AT bloembastiaanr assessmentofdualtaskinghasnoclinicalvalueforfallpredictioninparkinsonsdisease